🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this open-label, single-arm, multi-center phase II trial is ...
Status
Terminated
Location
National Cancer Center
Start Date
2013-03
Trial ID
NCT01819428
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of novel p...
Status
Completed
Location
National Cancer Center
Start Date
2015-04
Trial ID
NCT02418689
Treatments Being Tested
The purpose of this open-label, single-arm, multi-center phase II trial is ...
Status
Completed
Location
National Cancer Center
Start Date
2013-01
Trial ID
NCT01718847
Treatments Being Tested
This phase II trial tests whether poziotinib and ramucirumab work to shrink...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-06-16
Trial ID
NCT05045404
In this trial, treatment efficacy and safety of Poziotinib will be assessed...
Status
Completed
Location
Korean Association for the Study of Targeted Therapy
Start Date
2016-10
Trial ID
NCT02979821
Treatments Being Tested
\[Phase I\] The main objective of this study is to evaluate the safety, tol...
Status
Completed
Location
Seoul National University Hospital
Start Date
2012-11
Trial ID
NCT01746771
Treatments Being Tested
This phase II trial studies how well poziotinib works in treating patients ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2017-03-17
Trial ID
NCT03066206
Treatments Being Tested